Ten thousand kilometre transfer of cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation for emergency heart transplantation: Cooperation between Reunion Island and Metropolitan France

Abstract

Background:

There is no heart transplantation centre on the French overseas territory of Reunion Island (distance of 10,000 km). The aim of this study was to describe the characteristics of cardiogenic shock adult patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) who were transferred from Reunion Island to mainland France for emergency heart transplantation.

Methods:

This retrospective observational study was conducted between 2005 and 2015. The characteristics and outcome of cardiogenic shock patients on VA-ECMO were compared with those of cardiogenic shock patients not on VA-ECMO.

Results:

Thirty-three cardiogenic shock adult patients were transferred from Reunion Island to Paris for emergency heart transplantation. Among them, 19 (57.6%) needed mechanical circulatory support in the form of VA-ECMO. Median age was 51 (33–57) years and 46% of the patients had ischaemic heart disease. Patients on VA-ECMO presented higher Sequential Organ Failure Assessment score (p = 0.03). No death occurred during the medical transfer by long flight, while severe complications occurred in 10 patients (30.3%). Incidence of thromboembolic events, severe infectious complications and major haemorrhages was higher in the group of patients on VA-ECMO than in the group of patients not on VA-ECMO (p <0.01). Seven patients from the VA-ECMO group (36.8%) and six patients from the non-VA-ECMO group (42.9%, p=0.7) underwent heart transplantation after a median delay of 10 (4–29) days on the emergency waiting list. After heart transplantation, one-year survival rates were 85.7% for patients on VA-ECMO and 83.3% for patients not on VA-ECMO (p=0.91).

Conclusions:

This study suggests the feasibility of very long-distance medical evacuation of cardiogenic shock patients on VA-ECMO for emergency heart transplantation, with acceptable long-term results.

Keywords

Heart transplantation emergency venoarterial extracorporeal membrane oxygenation

Get full access to this article

View all access options for this article.

References

Rihal

Naidu

Givertz

et al . 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol 2015; 65: e7–e26.

Yusen

Edwards

Dipchand

et al . The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult lung and heart-lung transplant report–2016; focus theme: Primary diagnostic indications for transplant. J Heart Lung Transplant 2016; 3: 1170–1184.

Agence de la biomédecine. Le rapport médical et scientifique du prélèvement et de la greffe en France. Greffe cardiaque 2015. Available at: https://www.agence-biomedecine.fr/annexes/bilan2015/donnees/organes/03-coeur/synthese.htm (accessed June 2017).

Krim

Vivo

Campbell

et al . Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant 2015; 34: 912–920.

Maillot

Bussienne

Braunberger

et al . Long-distance air transfer on commercial long-haul flights for patients on extracorporeal life support. Intensive Care Med 2016; 42: 949–950.

Levy

Bastien

Karim

et al . Experts’ recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care 2015; 5: 52.

Schmidt

Brechot

Hariri

et al . Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 2012; 55: 1633–1641.

Sun

Tsai

et al . Infections occurring during extracorporeal membrane oxygenation use in adult patients. J Thorac Cardiovasc Surg 2010; 140: 1125–1132 e2.

Riebandt

Haberl

Mahr

et al . Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg 2014; 46: 486–492.

10.

Sabashnikov

Mohite

Weymann

et al . Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation. Eur J Cardiothorac Surg 2014; 46: e59–e66.

11.

Ponikowski

Voors

Anker

et al . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891–975.

12.

Kirklin

. Terminal heart failure: Who should be transplanted and who should have mechanical circulatory support? Curr Opin Organ Transplant 2014; 19: 486–493.

13.

Moreno-Cabral

Nakaahiki

. Cardiac transplantation in Hawaii. Hawaii Med J 1994; 53: 80–84.

14.

Moreno-Cabral

Wong

McNamara

et al . The first heart transplant operation in Hawaii and the prophylactic use of monoclonal antibodies (OKT3): A case report. Hawaii Med J 1988; 47: 177–181.

15.

Hong

Bailey

Kindle

et al . Cardiac transplantation in Hawai’i: A summary of the first 21 years. Hawaii Med J 2008; 67: 289–291.

16.

Arnaoutakis

George

Allen

et al . Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg 2012; 143: 157–167, 67 e1.